Speaking to Reuters TV, BioNTech Chief Executive Ugur Sahin said on Wednesday if all goes well, the U.S. Food and Drug Administration could grant emergency-use by Christmas.
Midmorning With Aundrea - November 20, 2020 (Part 1)
(Part 1 of 4) In a huge move toward a coronavirus vaccine in the US, Pfizer and the German pharmaceutical company BioNTech are..
WCBI